PAVMZ | PAVmed Inc Stock Overview

(Stock Exchange: NASDAQ)

Day's Range	0.0151 - 0.0151
52 Week Range	0.0151 - 0.0151
Beta	N/A
Implied Volatility	N/A
IV Rank	N/A
Day's Volume	748
Average Volume	N/A
Shares Outstanding	269,203,350
Market Cap	4,064,983
Sector	Healthcare
Industry	Medical - Devices
IPO Date	2018-04-10

Valuation
Profitability
Growth
Health
P/E Ratio	N/A
Forward P/E Ratio	N/A
EPS	N/A
1YR Price Target	N/A
Dividend Yield	N/A
Dividend Per Share	N/A
Dividend ExDate	N/A
Dividend PayDate	N/A
Employees	107
Country	USA
Website	PAVMZ

PAVmed Inc. operates as a medical device company in the United States. The company's lead products include CarpX, a patented, single-use, disposable, and minimally invasive surgical device for use in the treatment of carpal tunnel syndrome; and EsoCheck, an esophageal cell collection device for the early detection of adenocarcinoma of the esophagus and Barrett's Esophagus (BE); and EsoGuard, a bisulfite-converted next-generation sequencing DNA assay. Its product pipeline also comprises EsoCure, an esophageal ablation device to treat dysplastic BE; PortIO, an implantable intraosseous vascular access device; NextFlo; and Veris cancer care platform. The company was formerly known as PAXmed Inc. and changed its name to PAVmed Inc. in April 2015. PAVmed Inc. was incorporated in 2014 and is headquartered in New York, New York.

PAVMZ's peers: LUCD, NESRW, MNTX, AMSC, USAK, FSTR, KERNW, TWIN, GENC, ISSC, EML, CREXW, XAIR

*Chart delayed

Analyzing fundamentals for PAVMZ we got that it has weak fundamentals where Valuation is considered to be significantly overvalued, Profitability is poor, Growth is very bad and Health is frighteningly weak. For more detailed analysis please see PAVMZ Fundamentals page.

Watching at PAVMZ technicals we can see that long-term trend is bearish, the same as bearish middle-term trend, as well as bearish short-term trend. More technicals details can be found on PAVMZ Technicals page.